Atea Pharmaceuticals, Inc. (AVIR)
3.195
+0.04
(+1.11%)
USD |
NASDAQ |
Dec 11, 13:39
Atea Pharmaceuticals Total Assets (Quarterly): 342.96M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| AbbVie, Inc. | 133.90B |
| KORU Medical Systems, Inc. | 27.10M |
| Erasca, Inc. | 420.40M |
| Coya Therapeutics, Inc. | 32.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.18M |
| Shareholders Equity (Quarterly) | 315.78M |
| Debt to Equity Ratio | 0.0033 |
| Current Ratio | 16.66 |
| Net Debt Paydown Yield | 0.09% |